Literature DB >> 8345796

An evaluation of fetal glucogenesis in intrauterine growth-retarded pregnancies.

A M Marconi1, I Cetin, E Davoli, A M Baggiani, R Fanelli, P V Fennessey, F C Battaglia, G Pardi.   

Abstract

The presence of fetal glucogenesis was evaluated in nine patients with pregnancies complicated by intrauterine growth retardation (IUGR) at the time of fetal blood sampling (FBS) between 29 and 35 weeks of pregnancy. Eight were singleton pregnancies and one was a twin pregnancy in which blood samples were obtained from both twins. A maternal primed-constant infusion of D(U-13C]glucose was performed, and the presence of fetal glucogenesis was assessed by a comparison of steady-state maternal and fetal glucose enrichments. No significant difference was present between maternal and fetal molar percent excess ([MPE] P = .97), and the mean fetal to maternal (F/M) MPE ratio (0.99 +/- 0.01) was not significantly different from 1 (P = .76). F/M MPE ratio was independent of the time of FBS and umbilical venous glucose and lactate concentrations. Thus fetal glucogenesis is not demonstrable in a group of fairly severe growth-retarded fetuses after an overnight fast with this relatively noninvasive approach.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345796     DOI: 10.1016/0026-0495(93)90060-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

Review 1.  Clinical studies linking fetal velocimetry, blood flow and placental transport in pregnancies complicated by intrauterine growth retardation (IUGR).

Authors:  Frederick C Battaglia
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

2.  Glucose transporter 3 (GLUT3) protein expression in human placenta across gestation.

Authors:  K Brown; D S Heller; S Zamudio; N P Illsley
Journal:  Placenta       Date:  2011-10-14       Impact factor: 3.481

3.  Placental glucose transporter 3 (GLUT3) is up-regulated in human pregnancies complicated by late-onset intrauterine growth restriction.

Authors:  C Janzen; M Y Y Lei; J Cho; P Sullivan; B-C Shin; S U Devaskar
Journal:  Placenta       Date:  2013-08-28       Impact factor: 3.481

Review 4.  Placental metabolic reprogramming: do changes in the mix of energy-generating substrates modulate fetal growth?

Authors:  Nicholas P Illsley; Isabella Caniggia; Stacy Zamudio
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

Review 5.  The pregnant sheep as a model for human pregnancy.

Authors:  J S Barry; R V Anthony
Journal:  Theriogenology       Date:  2007-11-05       Impact factor: 2.740

6.  Augmented glucose production is not contingent on high catecholamines in fetal sheep with IUGR.

Authors:  Melissa A Davis; Leticia E Camacho; Alexander L Pendleton; Andrew T Antolic; Rosa I Luna-Ramirez; Amy C Kelly; Nathan R Steffens; Miranda J Anderson; Sean W Limesand
Journal:  J Endocrinol       Date:  2021-05-13       Impact factor: 4.286

7.  Pre-implantation exogenous progesterone and pregnancy in sheep. II. Effects on fetal-placental development and nutrient transporters in late pregnancy.

Authors:  Katherine M Halloran; Emily C Hoskins; Claire Stenhouse; Robyn M Moses; Kathrin A Dunlap; M Carey Satterfield; Heewon Seo; Gregory A Johnson; Guoyao Wu; Fuller W Bazer
Journal:  J Anim Sci Biotechnol       Date:  2021-04-08

8.  Hypoglycemia and the origin of hypoxia-induced reduction in human fetal growth.

Authors:  Stacy Zamudio; Tatiana Torricos; Ewa Fik; Maria Oyala; Lourdes Echalar; Janet Pullockaran; Emily Tutino; Brittney Martin; Sonia Belliappa; Elfride Balanza; Nicholas P Illsley
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.